Elinzanetant is the first neurokinin-targeted therapy to demonstrate efficacy in reducing vasomotor symptoms (VMS)” — ...

Rezpegaldesleukin, an investigational interleukin-pathway agonist, demonstrated efficacy and safety for people with moderate ...

In a Healio video exclusive, Edward V. Loftus Jr., MD, discusses the rise in popularity of liver cleanses, often spurred by ...